- Latest available (Revised)
- Point in Time (22/12/2020)
- Original (As adopted by EU)
Commission Implementing Decision (EU) 2020/2212 of 22 December 2020 amending the Annex to Decision 2007/453/EC as regards the BSE status of the United Kingdom and the Crown Dependency of Jersey (notified under document C(2020) 9453) (Text with EEA relevance)
After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.
The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.
Point in time view as at 22/12/2020.
There are currently no known outstanding effects for the Commission Implementing Decision (EU) 2020/2212.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies(1), and in particular the third subparagraph of Article 5(2) thereof,
Whereas:
(1) Regulation (EC) No 999/2001 provides that Member States, third countries or regions thereof are to be classified according to their bovine spongiform encephalopathy (BSE) status into one of three categories: negligible BSE risk, controlled BSE risk and undetermined BSE risk.
(2) The third subparagraph of Article 5(2) of Regulation (EC) No 999/2001 provides that if the World Organisation for Animal Health (OIE) has placed an applicant country in one of the three BSE categories, a re-assessment of the BSE categorisation at Union level may be decided.
(3) Commission Decision 2007/453/EC(2) lists the BSE status of countries or regions according to their BSE risk in Parts A, B or C of the Annex to that Decision. The countries and regions listed in Part A of that Annex are regarded as having a negligible BSE risk, those listed in Part B thereof are regarded as having a controlled BSE risk, while Part C of that Annex provides that countries or regions not listed in Part A or B are to be regarded as having an undetermined BSE risk.
(4) Northern Ireland and Scotland currently fall within Part A of the Annex to Decision 2007/453/EC as regions with a negligible BSE risk, while the United Kingdom with the exception of Northern Ireland and Scotland currently falls within Part B of that Annex as a country with a controlled BSE risk.
(5) On 28 May 2019, during its General Session, the OIE World Assembly of Delegates adopted Resolution No 19 on the Recognition of the Bovine Spongiform Encephalopathy Risk Status of Members(3), in view of an entry into force on 31 May 2019. That Resolution recognised Scotland as having a controlled BSE risk. After reassessment of the situation at Union level, stemming from that OIE Resolution, the Commission has considered that the new OIE BSE status of Scotland should be reflected in Decision 2007/453/EC.
(6) On 29 May 2020, the OIE World Assembly of Delegates adopted Resolution No 11(4) recognising Jersey as having a negligible BSE risk, in accordance with the Terrestrial Animal Health Code of the OIE. After reassessment of the situation at Union level, stemming from that OIE Resolution, the Commission has considered that the new OIE BSE status of Jersey should be reflected in Decision 2007/453/EC.
(7) The United Kingdom submitted an application to the Commission for its BSE status and that of the Crown Dependency of Jersey. This application was accompanied by the relevant information for the United Kingdom and the Crown Dependency of Jersey on the criteria and potential risk factors referred to in Article 5(2) of Regulation (EC) No 999/2001 and set out in Chapters A and B of Annex II to that Regulation. Taking into account the information provided by the United Kingdom, that third country should be included in Part B of the Annex to Decision 2007/453/EC, while the Crown Dependency of Jersey should be included in Part A of that Annex.
(8) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (Withdrawal Agreement), and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, Regulation (EC) No 999/2001, as well as the Commission acts based on it, applies to and in the United Kingdom in respect of Northern Ireland after the end of the transition period provided for in the Withdrawal Agreement. For that reason, at the end of the transition period only Northern Ireland should be listed as a region of a Member State in Part A of the Annex to Decision 2007/453/EC.
(9) The Annex to Decision 2007/453/EC should therefore be amended accordingly.
(10) As the transition period provided for in the Withdrawal Agreement ends on 31 December 2020, this Decision should apply from 1 January 2021.
(11) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
The Annex to Decision 2007/453/EC is replaced by the text set out in the Annex to this Decision.
This Decision shall apply from 1 January 2021.
This Decision is addressed to the Member States.
Done at Brussels, 22 December 2020.
For the Commission
Stella Kyriakides
Member of the Commission
Member States
Belgium
Bulgaria
Czechia
Denmark
Germany
Estonia
Spain
Croatia
Italy
Cyprus
Latvia
Lithuania
Luxembourg
Hungary
Malta
Netherlands
Austria
Poland
Portugal
Romania
Slovenia
Slovakia
Finland
Sweden
Regions of Member States (5)
Northern Ireland
European Free Trade Association countries
Iceland
Liechtenstein
Norway
Switzerland
Third countries
Argentina
Australia
Brazil
Chile
Colombia
Costa Rica
India
Israel
Japan
Jersey
Namibia
New Zealand
Panama
Paraguay
Peru
Serbia(6)
Singapore
United States
Uruguay
Member States
Ireland
Greece
France
Third countries
Canada
Mexico
Nicaragua
South Korea
Taiwan
United Kingdom with the exception of Northern Ireland
Countries or regions not listed in Parts A or B’’.
Commission Decision 2007/453/EC of 29 June 2007 establishing the BSE status of Member States or third countries or regions thereof according to their BSE risk (OJ L 172, 30.6.2007, p. 84).
http://www.oie.int/fileadmin/Home/eng/Animal_Health_in_the_World/docs/pdf/Resolutions/2019/A_R19_BSE_risk.pdf.
https://www.oie.int/fileadmin/Home/eng/About_us/docs/pdf/Session/2020/A_RESO_2020.pdf
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.
As referred to in Article 135 of the Stabilisation and Association Agreement between the European Communities and their Member States of the one part, and the Republic of Serbia, of the other part (OJ L 278, 18.10.2013, p. 16).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: